Compare, Analyse STRIDES PHARMA SCIENCE with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE vs MYLAN (US) - Comparison Results

STRIDES PHARMA SCIENCE     Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STRIDES PHARMA SCIENCE   MYLAN
EQUITY SHARE DATA
    STRIDES PHARMA SCIENCE
Mar-18
MYLAN
Dec-18
STRIDES PHARMA SCIENCE/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,1473,498-   
Low Rs6421,925-   
Sales per share (Unadj.) Rs317.21,609.6-  
Earnings per share (Unadj.) Rs7.843.7-  
Cash flow per share (Unadj.) Rs25.1345.1-  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs274.31,741.3-  
Shares outstanding (eoy) m89.50514.50-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.81.7 167.4%   
Avg P/E ratio x114.062.0 183.8%  
P/CF ratio (eoy) x35.77.9 454.3%  
Price / Book Value ratio x3.31.6 209.4%  
Dividend payout %25.50-   
Avg Mkt Cap Rs m80,0581,395,211 5.7%   
No. of employees `0002.535.0 7.2%   
Total wages/salary Rs m4,3410-   
Avg. sales/employee Rs Th11,325.823,661.7 47.9%   
Avg. wages/employee Rs Th1,731.40-   
Avg. net profit/employee Rs Th280.1642.5 43.6%   
INCOME DATA
Net Sales Rs m28,394828,159 3.4%  
Other income Rs m9410-   
Total revenues Rs m29,334828,159 3.5%   
Gross profit Rs m3,965214,297 1.9%  
Depreciation Rs m1,540155,064 1.0%   
Interest Rs m1,96239,832 4.9%   
Profit before tax Rs m1,40319,401 7.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-1680-   
Extraordinary Inc (Exp) Rs m-4360-   
Tax Rs m97-3,087 -3.2%   
Profit after tax Rs m70222,488 3.1%  
Gross profit margin %14.025.9 54.0%  
Effective tax rate %6.9-15.9 -43.6%   
Net profit margin %2.52.7 91.1%  
BALANCE SHEET DATA
Current assets Rs m24,836462,443 5.4%   
Current liabilities Rs m18,993337,172 5.6%   
Net working cap to sales %20.615.1 136.0%  
Current ratio x1.31.4 95.3%  
Inventory Days Days7184 84.9%  
Debtors Days Days11393 121.5%  
Net fixed assets Rs m34,289160,649 21.3%   
Share capital Rs m895441 203.0%   
"Free" reserves Rs m23,6510-   
Net worth Rs m24,546895,917 2.7%   
Long term debt Rs m15,513966,981 1.6%   
Total assets Rs m65,4372,403,196 2.7%  
Interest coverage x1.71.5 115.3%   
Debt to equity ratio x0.61.1 58.6%  
Sales to assets ratio x0.40.3 125.9%   
Return on assets %4.12.6 157.0%  
Return on equity %2.92.5 114.0%  
Return on capital %6.93.2 216.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m14,9620-   
CASH FLOW
From Operations Rs m1,871172,092 1.1%  
From Investments Rs m5,826-88,952 -6.5%  
From Financial Activity Rs m-10,157-80,170 12.7%  
Net Cashflow Rs m-2,6151,426 -183.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.49 Rs / USD

Compare STRIDES PHARMA SCIENCE With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare STRIDES PHARMA SCIENCE With: PIRAMAL ENTERPRISES  GLENMARK PHARMA  FRESENIUS KABI ONCO.  JUBILANT PHARMOVA   PFIZER  



Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY21); Net Profit Down 46.4% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, STRIDES PHARMA SCIENCE has posted a net profit of Rs 621 m (down 46.4% YoY). Sales on the other hand came in at Rs 8 bn (up 13.6% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY21); Net Profit Up 184.5% (Quarterly Result Update)

Aug 20, 2020 | Updated on Aug 20, 2020

For the quarter ended June 2020, STRIDES PHARMA SCIENCE has posted a net profit of Rs 1 bn (up 184.5% YoY). Sales on the other hand came in at Rs 8 bn (up 14.0% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Worst Sector in the Market (Fast Profits Daily)

May 11, 2021

The worst sector in the stock market according to the charts.

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

STRIDES PHARMA SCIENCE SHARE PRICE


May 14, 2021 (Close)

TRACK STRIDES PHARMA SCIENCE

  • Track your investment in STRIDES PHARMA SCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE 8-QTR ANALYSIS

COMPARE STRIDES PHARMA SCIENCE WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS